Figure 7
CHKA silencing induce sensitivity to drug treatment. Cytotoxicity assay: Sensitivity to: (A) cisplatinum (DDP, from 1 × 10−4 to 3 × 10−7 M); (B) Doxorubicin (from 1 × 10−4 to 1 × 10−7 M); (C) Paclitaxel (from 2.5 to 0.016 nM) was tested. Mean±s.d. of growth percentage of treated vs untreated cells is reported.
